Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection
2016 · Gastroenterology · 320 citations
https://doi.org/10.1053/j.gastro.2016.02.072
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
5.5K
Citations
29
h-index
38
i10-index
Michael Safdi is an academic researcher from Janssen (United States). The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Colorectal Cancer Screening and Detection. The author has an h-index of 29, co-authored 47 publications.
https://doi.org/10.1053/j.gastro.2016.02.072
https://doi.org/10.1093/ibd/izx072
Click to start Chat